Zealand Pharma Shares Drop Amid Safety Concerns Over Weight-Loss Drug
Shares of Zealand Pharma fell as much as 26% after data from its experimental weight-loss drug, survodutide, raised safety concerns. The Danish company reported that the treatment met certain criteria but triggered worries about potential side effects.
